A5016893846- Heart Failure Treatment and Management
- Medication Adherence and Compliance
- Potassium and Related Disorders
- Chronic Disease Management Strategies
- Iron Metabolism and Disorders
- Erythropoietin and Anemia Treatment
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Membrane-based Ion Separation Techniques
- Health Systems, Economic Evaluations, Quality of Life
- Nursing care and research
- Cardiovascular Function and Risk Factors
- Cardiac Health and Mental Health
- Pharmaceutical Practices and Patient Outcomes
- Dementia and Cognitive Impairment Research
- Health Literacy and Information Accessibility
- Telemedicine and Telehealth Implementation
- Cardiac electrophysiology and arrhythmias
- Chemotherapy-induced cardiotoxicity and mitigation
- Mobile Health and mHealth Applications
- Hemoglobinopathies and Related Disorders
- Myasthenia Gravis and Thymoma
- Aging, Health, and Disability
- Acute Myocardial Infarction Research
Bellvitge University Hospital
2017-2024
Institut d'Investigació Biomédica de Bellvitge
2017-2024
Universitat de Barcelona
2023
University of Alicante
2022
Institut Català d'Oncologia
2020
The effects of iron deficiency (ID) have been widely studied in heart failure (HF) with reduced ejection fraction. On the other hand, studies HF preserved fraction (HFpEF) are few and included small numbers participants. aim this study was to assess role that ID plays functional capacity quality life (QoL) HFpEF while comparing several iron-related biomarkers be used as potential predictors. defined ferritin <100 ng/mL or transferrin saturation <20%. Submaximal exercise capacity,...
Abstract Aims The assumption that improved self-care in the setting of heart failure (HF) care necessarily translates into improvements long-term mortality and/or hospitalization is not well established. We aimed to study association between and other major adverse HF events (MAHFE). Methods results conducted an observational, prospective, cohort 1123 consecutive patients with chronic HF. primary endpoint was all-cause mortality. used European Heart Failure Self-care Behaviour Scale 9-item...
Abstract Background Iron deficiency (ID) is common in patients with heart failure (HF) and associated poor outcomes, yet its role the pathophysiology of HF not well-defined. We sought to determine consequences neurohormonal activation iron homeostasis mitochondrial function cardiac cells. Methods was induced C57BL/6 mice by using isoproterenol osmotic pumps embryonic rat heart-derived H9c2 cells were subsequently challenged Angiotensin II and/or Norepinephrine. The expression several genes...
Objectives To gather insights on the disease experience of patients with heart failure (HF) reduced ejection fraction (HFrEF), and assess how patients’ experiences narratives related to complement data collected through standardised patient-reported outcome measures (PROMs). Also, explore new ways evaluating burden experienced by caregivers. Design Observational, descriptive, multicentre, cross-sectional, mixed-methods study. Setting Secondary care, patient’s homes. Participants Twenty HFrEF...
Cardiovascular disease is a common problem in cancer patients that becoming more widely recognized. This may be consequence of prior cardiovascular risk factors but could also secondary to the anticancer treatments. With goal offering multidisciplinary approach guaranteeing optimal therapy and early detection related cardiac diseases, light recent ESC Cardio-Oncology Guideline recommendations, we developed unit devoted prevention management these specific complications. document brings...
Background and aims Heart failure (HF) programs successfully reduce 30-day readmissions. However, conflicting data exist about its sustained effects afterwards impact on mortality. We evaluated whether the of a new nurse-led coordinated transitional HF program extends to longer periods time, including 90 180 days after discharge. Methods results designed natural experiment undertake pragmatical evaluation implementation program. compared outcomes between patients discharged with as primary...
Background: The aims of the present analysis are to estimate prevalence five key chronic cardiovascular, metabolic and renal conditions at population level, renin–angiotensin–aldosterone system inhibitor (RAASI) medication use magnitude potassium (K + ) derangements among RAASI users. Methods Results: We used data from more than 375,000 individuals, 55 years age or older, included in population-based healthcare database Catalan Institute Health between 2015 2017. interest were heart failure...
Abstract Background/introduction Heart failure (HF) can negatively affect health-related quality of life (HRQoL) in HF patients by reducing their independence and limiting daily activities. Patient-reported outcome measures (PROMs), such as HRQoL, are useful indicators to health status have good correlation with prognosis. In the past years addition telemedicine (TM) programmes has emerged a promising strategy for management chronic patients. However, there is little information about impact...
Abstract Background The implementation of a process-oriented organizational structure in patient care allows for comprehensive and optimized approach. In the context heart failure (HF), it remains uncertain whether establishment specialized hospitalisation team can contribute to improved major clinical outcomes. Purpose To analyse rates all-cause hospitalisation, cardiovascular hospitalization, HF hospitalization overall mortality at 180 days among patients admitted Cardiology ward HF, both...
Abstract Background Soluble receptor of transferrin (sTfR) is a marker tissue iron status and may help to inform on subtle depletion increased demand at tissular level even in the absence overt systemic deficiency or anaemia. In this regard, impact raised sTfR levels as (ID) serum biomarkers non-anaemic HF patients with otherwise normal has not been evaluated. Purpose The aim our study was describe association between cardiac, systemic, neurohormonal hematinic status. Methods We conducted an...
Abstract Background/introduction Poor self-care in heart failure (HF) patients is well recognised to lead a worse prognosis, through an increased risk of readmissions and mortality. In this regard, the integration eHealth-based telemonitoring tele-intervention tools into integrated HF-care programmes could help improve these patients. Nevertheless, current evidence regarding impact eHealth solutions on HF scarce. Purpose To evaluate effect telemedicine (TM) behaviour with after hospital...
Abstract Background High comorbidity burden has a negative impact in terms of outcomes and medical resource use despite access to integrated care universal health-care systems patients with heart failure (HF). Whether the breach determined by can be mitigated intensive HF management programs is not known. Purpose To analyse effectiveness across morbidity groups on health before after pragmatic implementation an transitional nurse-based program healthcare area 209,255 inhabitants. Methods We...
Abstract Background Old age has a negative impact in terms of outcomes and medical resource use patients with heart failure (HF). The efficacy HF management programs been widely proved, however the influence effectiveness is still unknown. Purpose To analyze effect on health before after pragmatic implementation an intensive transitional care nurse-based program integrating hospital primary resources for at high risk events health-care area 209,255 inhabitants. Methods For purposes this...
Abstract Background Soluble receptor of transferrin (sTfR) is a marker tissue iron status and may help to inform on subtle depletion increased demand functional proteins at tissular level even in the absence systemic deficiency or anaemia. Raised sTfR levels have been associated with all-cause mortality impaired exercise capacity patients heart failure (HF). However, impact quality life (QoL) has not evaluated. Purpose The aim our study was describe association between as QoL non-anaemic HF...
Abstract Background Soluble receptor of transferrin (sTfR) is a marker tissue iron status and may help to inform on subtle depletion increased demand at tissular level even in the absence overt systemic deficiency or anaemia. In this regard, impact raised sTfR levels as ID functional limitation submaximal exercise capacity non-anaemic HF patients with normal has not been evaluated. Purpose To describe association between capacity, estimated distance walked 6-minutes walking test (6MWT),...